Front. Physiol. Frontiers in Physiology Front. Physiol. 1664-042X Frontiers Media S.A. 10.3389/fphys.2017.00049 Physiology Review Muro-Neuro-Urodynamics; a Review of the Functional Assessment of Mouse Lower Urinary Tract Function Ito Hiroki 1 Pickering Anthony E. 1 Igawa Yasuhiko 2 Kanai Anthony J. 3 Fry Christopher H. 1 Drake Marcus J. 1 * 1Department of Physiology, Pharmacology and Neuroscience, University of Bristol Bristol, UK 2Department of Continence Medicine, University of Tokyo Graduate School of Medicine Tokyo, Japan 3Department of Pharmacology and Chemical Biology, University of Pittsburgh Pennsylvania, PA, USA

Edited by: Christine Kranz, University of Ulm, Germany

Reviewed by: Peter Zvara, University of Vermont, USA; Warren G. Hill, Beth Israel Deaconess Medical Center, USA

*Correspondence: Marcus J. Drake marcus.drake@bristol.ac.uk

This article was submitted to Renal and Epithelial Physiology, a section of the journal Frontiers in Physiology

 06 02 2017 2017 8 49 01 11 2016 18 01 2017 Copyright © 2017 Ito, Pickering, Igawa, Kanai, Fry and Drake. 2017 Ito, Pickering, Igawa, Kanai, Fry and Drake

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

Background: Mouse urodynamic tests are fundamental to understanding normal lower urinary tract (LUT) function. These experiments also contribute to our understanding of neurological dysfunction, pathophysiological processes, and potential mechanisms of therapy.

Objectives: Systematic assessment of published evidence on urodynamics, advantages and limitations of different urodynamic measurements in mice, and consideration of potential implications for the clinical field.

Methods: A search using specific search-terms for urodynamic studies and mice was conducted on PubMed (from inception to 1 July 2016).

Results: We identified 55 studies examining or describing mouse neuro-urodynamics. We summarize reported features of mouse urodynamic function deriving from frequency-volume chart (FVC) measurements, voiding spot assays, filling cystometry, and pressure-flow studies. Similarly, an influence of the diurnal cycle on voiding is observed in mice and should be considered when interpreting rodent urodynamic studies, especially FVC measurements and voiding spot assays. Anaesthesia, restraint conditions, or filling rate influence mouse neuro-urodynamics. Mouse cystometric studies have observed intravesical pressure oscillations that accompany urine flow, attributed to high frequency opening and closing of the urethra. This characterization is not seen in other species, except rats. In contrast to human clinical urodynamics, the terminology of these examinations has not been standardized although many rodent urodynamic studies have been described.

Conclusion: Mice have many anatomical and physiological similarities to humans and they are generally cost effective, and allow investigation of the effects of aging because of their short lifespan. There are some differences between mouse and human urodynamics. These must be considered when interpreting LUT function in mice, and translational value of murine disease models.

 mouse model lower urinary tract dysfunction cystometry electromyography of the external urethral sphincter frequency-volume chart Foundation for the National Institutes of Health10.13039/100000009 Background

The neuro-urodynamic control of the lower urinary tract (LUT) requires precise choreography between the central and peripheral nervous systems. These neural mechanisms are complex and impairment are associated with voiding and storage dysfunction; for example, overactive bladder (OAB), urinary incontinence or detrusor underactivity. In clinical practice, human urodynamic studies evaluate the function of the LUT and are useful in the assessment and diagnosis of patients with a broad range of lower urinary tract symptoms (LUTS) (Drake et al., 2016).

A mammalian model is fundamental to understanding LUT function, and these experiments also contribute to our understanding of pathophysiological processes. Rodents have useful anatomical and physiological similarities to humans, and are generally cost effective. Their short lifespan (about 2 years) means it is feasible to evaluate the effects of aging. Rodent urodynamic studies, such as filling cystometry, pressure-flow studies, or neural activity recording, provide crucial information to enable mechanistic insights into the basis of neural control. In the clinical field, the terminology and practice of urodynamic studies have been developed by the International Continence Society (ICS), to standardize such measurements. Given the importance of animal models, a variety of techniques have been adopted to measure pressures in the rodent LUT and proposals made to standardize terminology (Fry et al., 2010; Andersson et al., 2011). Rats are a useful animal model for neuro-urodynamic studies in part because their bladders have been well-characterized by both in vitro and in vivo experiments.

On the other hand, the urodynamic properties of the mouse LUT have not been characterized as well as those of other rodents. This is possibly because mice are more difficult to handle and the in vitro/in vivo properties are more poorly understood (Uvin et al., 2012). However, the ability to generate genetically-modified mice can provide valuable mechanistic insights and therefore it is appropriate to consider mouse urodynamics in the context of current developments. The present review covers recent knowledge of mouse urodynamics and considers potential implications in the clinical field. In addition the limitations of urodynamic measurements in mice are discussed.

 Normal micturition cycle in mice

In neonatal mice, maternal parenting exploits a perineal-to-bladder reflex to trigger voiding. The adult form of voiding triggered by bladder distension does not become functional until several weeks after birth. As the adult reflex appears, the neonatal perineal-to-bladder reflex becomes weaker and eventually disappears (de Groat et al., 1998).

Rodents pass urine with a nocturnal predominance in voiding frequency (Ito et al., 2015; Yoshiyama et al., 2015). Figure 1 is a 24-h trace of frequency-volume chart (FVC) measurements of male mice at the age of 10 weeks and clearly demonstrates that there are notable differences in the voiding behavior and water intake between daytime and night-time. These FVC measurements indicate that young mice (10-weeks old) of both genders usually urinate about 10 times per day, and urination occurs mainly in the dark cycle due, for this nocturnal animal (Aizawa et al., 2013).

A 24-h trace of a frequency-volume charts (FVC) (upper) and water intake (lower) of a male mouse at the age of 10 weeks. Each animal was separately placed in a conscious condition, without any restraint, in a metabolic cage that allows precise measurement of voiding episodes, voided volume, drinking episodes, and amounts (001–006 metMCM/TOA-UFabolic cage, Mitsubishi Chemical Medience, Tokyo, Japan). After 24-h adaptation, voided volume, voiding frequency, and water intake volume were recorded using a PowerLab® data acquisition system continuously for 24 h starting at 9:00 pm. The mice had free access to water and food during recording.

Mice are highly social animals and adapt to their surroundings. It is important for precise assessment of mouse voiding behavior to allow for adequate adaptation periods before experiments once animals are moved into a new environment to minimize stress and anxiety. In addition, mice of both sexes use urinary scent marks for territorial communication. Urinary scent incorporates information about individuals (such as species, sex, and individual identity) as well as metabolic information (such as social dominance, and reproductive and health status) (Arakawa et al., 2008; Hou et al., 2016). Voids used for territorial marking seem to be similar to non-territorial voids of mice, and there are no clear criteria to distinguish them in vivo.

 Urodynamic techniques available for mice

Given the potential translational relevance of mouse urodynamics, we describe the published evidence in sequence akin to the progressive approach taken in clinical urodynamics (Table 1). Mouse urodynamic function is mainly determined by FVC measurements, voiding spot assays, filling cystometry, and pressure-flow studies. In this section, we summarize the literature for mouse urodynamics, and highlight uncertainties when interpreting their results.

Summary of clinical neuro-urodynamic tests for human and relevant mouse neuro-urodynamic tests.

Tests Neuro urodynamics
Human clinical technique Mouse technique
Non-invasive Symptom score Various questionnaires Not applicable
such as
International Prostate Symptom Score (IPSS)
QOL question
Bladder diary Micturition chart Metabolic cage
Frequency volume chart (FVC) Frequency volume chart (FVC)
Bladder diary Voiding Spot Assay (VSA)
Urodynamic tests Urinary flow rate Not applicable
Post-void urine (PVR) analysis
Other tests Near intra-red spectroscopy (NIRS) Phenotyping (Distended bladder, Perineal for staining)
Invasive Urodynamic tests Filling cystometry (storage phase) Filling cystometry (storage phase)
Pressure-flow study (voiding phase) Pressure-flow study (voiding phase)
Electrophysiology
Future Special tests Functional magnetic resonance imaging (fMRI) Functional magnetic resonance imaging (fMRI)
Positron emission tomography (PET) Positron emission tomography (PET)
Electrophysiology
Non-invasive tests (Table <xref ref-type="table" rid="T2">2</xref>)

Non-invasive tests may evoke less physical and psycological stress than invasive testing, and allow additional experimental observations to be made. Consequently, it is feasible to undertake longitudinal monitoring of processes like aging or disease progression.

Summary of non-invasive tests for mouse urodynamic studies.

Species Sex Weeks Body weight (g) Voided volume per micturition (μl) Day vs. night Reference
Metabolic cage C57BL/6J m 5 16.5 ± 0.3 104.3 ± 7.6 24 h Aizawa et al., 2013
9 22.0 ± 0.3 137.1 ± 5.4
13 24.3 ± 0.3 177.8 ± 8.6
17 25.6 ± 0.2 251.8 ± 15.4
21 26.9 ± 0.3 267.4 ± 22.5
WT (C57BL/6Cr) m 8–12 22.1 ± 0.3 about 380 24 h Yoshiyama et al., 2015
WT (129Sv and C57BL/6) f NA 15–23 490 ± 130 14 h (overnight) Sutherland et al., 1997
WT (129Sv and C57BL/6J) f 12 24.3 ± 0.9 160 ± 30 48 h Chen et al., 2005
Voiding spot assay 129S1/SvImJ m 10–12 27.1 ± 0.8 40.1 4 h (9 a.m.–2 p.m.) Bjorling et al., 2015
f 10–12 21.8 ± 0.8 103.7
C57BL/6J m 10–12 27.6 ± 0.5 86.7
f 10–12 19.2 ± 0.2 68.8
NOD/ShiLtJ m 10–12 29.1 ± 1.3 40
f 10–12 24.5 ± 0.4 51.9
CAST/EiJ m 10–12 16.6 ± 0.3 3.8
f 10–12 13.4 ± 0.6 15.9
WT (C57BL6) m 9–17 25.7 ± 1.1 NA 1 h Birder et al., 2002
C57BL/6 m NA 20–30 NA 1 h (8–11 a.m.) Cornelissen et al., 2008
f NA 20–30 NA
Balb/CAN m NA 20–30 NA
f NA 20–30 NA
A/J m NA 20–30 NA
f NA 20–30 NA
B6:129 m NA 20–30 NA
f NA 20–30 NA
129 m NA 20–30 NA
f NA 20–30 NA
WT (C57BL/6 and DBA/2) f 7–8 27.6 ± 2.25 430 ± 80 overnight 8 h Jusuf et al., 2001
C57BL/6 m 10–12 unknown 108.3 ± 14.1 3 h (unknown) Boudes et al., 2011

f, female; m, male; NA, not assessed; WT, wild type.

 Metabolic cage–frequency-volume chart measurements

Housing mice in metabolic cages enables the measurement of voiding behavior by quantifying the volume of urine drops of freely moving mice (Sutherland et al., 1997; Chen et al., 2005; Aizawa et al., 2013; Yoshiyama et al., 2015). Such FVC measurements using metabolic cages generally allow calculation of voided volume and voiding time, and previous studies have recorded voiding behavior for 14 h (overnight) (Sutherland et al., 1997), 24 h (Aizawa et al., 2013; Yoshiyama et al., 2015), and 48 h (Chen et al., 2005).

Voided volume and bladder capacity are much smaller in mice than in other rodents, so metabolic cages for FVC recording might be less accurate to measure the precise voided volume, because there is a potential problem with evaporation from small urine deposits.

In the FVC measurements, it is important for precise recording of voided volume to remove feces prior to entry into the measuring system. A novel metabolic cage, with a specially-designed net to separate urine from feces, has been recently described (Aizawa et al., 2013; Yoshiyama et al., 2015). This enables recording of precise voided volume, average flow rate, voiding frequency, and water intake of conscious mice continuously for more than 24 h.

As described above, an influence of the diurnal cycle on voiding is observed in mice and should be considered when interpreting rodent urodynamic studies, especially FVC measurements and voiding spot assays (VSA, below), and was achieved in the above papers. To measure precise mouse urinary storage function, mice need a prior adaptation period of more than 24 h.

 Voiding spot assay (VSA)

VSA is a widely used method to measure the FVC for free moving and awake mice (Birder et al., 2002; Cornelissen et al., 2008; Sugino et al., 2008; Boudes et al., 2011; Yu et al., 2014; Bjorling et al., 2015) and precise measurement of the voiding behavior of mice using a metabolic cage has space and cost implications. The VSA does not allow calculation of urine flow rate, but is useful to measure the pattern and volume of voiding. Voiding behavior is analyzed by placing the animal above or on a piece of filter paper (Jusuf et al., 2001). However, some have indicated that it is difficult to draw inferences about urodynamic parameters from voiding spots, at least in young healthy mice (Bjorling et al., 2015). In fact, some previous VSA studies in mice did not attempt to calculate the voided volume, but only the number of individual spots (Birder et al., 2002; Cornelissen et al., 2008).

The test period and timing in the light-dark cycle are crucial factors in voiding spot assays and FVC measurements, and most papers provide information about when the tests were done (Jusuf et al., 2001; Cornelissen et al., 2008; Yu et al., 2014; Bjorling et al., 2015). Thus, VSAs have been performed in the light phase of the cycle [for 1 h (Cornelissen et al., 2008) and 4 h (Bjorling et al., 2015)], in the overnight period [for 8 h (Jusuf et al., 2001)], but the diurnal phase was not stated in some [for 1 h (Birder et al., 2002) and 3 h (Boudes et al., 2011)].

A modified VSA system, called the automated voided stain on paper (aVSOP) method, has been developed to allow more detailed assessment over an extended time-frame (Negoro et al., 2012). This system has a motor to roll paper under the cage and collect urine stains. This can record accurately the number of voids, voiding frequency, and voided volume for several days.

 Invasive tests

Urodynamic studies in mice include filling cystometry and pressure-flow studies for the investigation of storage and voiding phases, respectively. Although many rodent urodynamic studies have been described, the terminology of these examinations has not been standardized. An absence of reliable terminology risks misinterpretation of the findings and also impedes effective cross referencing between studies and establishment of reference ranges for normality. Therefore, it is important to establish the terminology of rodent urodynamic studies. Only one paper provides a proposed standardization of terminology (Andersson et al., 2011), and this is a suitable reference point for research at the current time.

Testing method

Experimental techniques are well-developed and described in several papers (Fry et al., 2010; Andersson et al., 2011). After induction of anesthesia, a catheter is implanted in the bladder dome and tunneled subcutaneously to the abdominal skin incision or head position. The bladder is filled at a controlled rate, and cystometric parameters can be measured via the implanted catheter under non-restrained, restrained, or anesthetized conditions (Andersson et al., 2011; Uvin et al., 2012). In contrast to human clinical urodynamics, where the detrusor pressure is calculated as intravesical pressure minus abdominal pressure, measurement of abdominal pressure is seldom undertaken in mouse urodynamics. One report (Smith et al., 2012) did measure abdominal pressure to calculate detrusor pressure, but in others intravesical pressure is recorded alone (Sutherland et al., 1997; Lemack et al., 2000; Pandita et al., 2000; Jusuf et al., 2001; Birder et al., 2002; Schröder et al., 2003, 2004; Igawa et al., 2004; Chen et al., 2005; Cornelissen et al., 2008; Beamon et al., 2009; Smith and Kuchel, 2010; Soler et al., 2010; Aizawa et al., 2013; Bjorling et al., 2015; Yoshiyama et al., 2015; Franken et al., 2016).

Conscious mouse urodynamic studies have been undertaken under ambulatory or static conditions. Although ambulatory methods may be more physiological catheter problems are common, such as twisting and/or dislodging when using non-restrained mice. However, there are some technical tips to prevent catheter problems, such as securing the catheter to the skin at the point of its external exit, or between the skin and the bladder. Swiveling supports may help to minimize twisting of the tubing. On the other hand, the free-moving status often generates noise and artifacts in the cystometric tracing which can affect accurate analysis. Indeed a previous report indicated that it is difficult to obtain precise voiding volume reliably from awake mice cystometry (Smith and Kuchel, 2010).

Catheters implanted into the bladder in mouse urodynamics generally employ one of two diameters, PE 10 (internal/outer diameter is 0.28/0.61 mm) or PE 50 (internal/outer diameter is 0.58/0.97 mm) tubing. PE 50 is most commonly used for bladder cannulation in mouse urodynamics (Birder et al., 2002; Igawa et al., 2004; Cornelissen et al., 2008; Beamon et al., 2009; Smith and Kuchel, 2010; Boudes et al., 2011; Comiter and Phull, 2012; Smith et al., 2012; Aizawa et al., 2013; Bjorling et al., 2015; Yoshiyama et al., 2015; Franken et al., 2016) and some studies used PE10 for the same purpose (Sutherland et al., 1997; Pandita et al., 2000; Schröder et al., 2003, 2004; Soler et al., 2010; Mingin et al., 2015). PE 10 is thinner and softer than PE 50, which might decrease the physical stress and inflammation caused by catheter implantation in the bladder. However, the small diameter may increase the risk of artifacts during measurements, and potentially failure to measure pressure reliably (Smith and Kuchel, 2010). Although there is a need to compare the merits and disadvantages of the catheter options, the authors were unable to identify any published comparison.

The implantation of a catheter into the bladder dome may cause infection, inflammation or edema in the mucosa and submucosa area, which might influence the cystometric results. In mouse urodynamic studies, catheterization into the bladder is generally done shortly before cystometry. Previous reports, however, show variation in the time interval between catheter implantation and cystometry; 0 day (Sutherland et al., 1997; Lemack et al., 2000; Jusuf et al., 2001; Streng et al., 2002a,b; Boudes et al., 2011; Comiter and Phull, 2012; Smith et al., 2012; Yu et al., 2014; Bjorling et al., 2015; Yoshiyama et al., 2015; Franken et al., 2016), 2 days (Schröder et al., 2003, 2004; Chen et al., 2005; Smith and Kuchel, 2010), 3 days (Pandita et al., 2000; Igawa et al., 2004; Soler et al., 2010; Mingin et al., 2015), 4 days (Aizawa et al., 2013), and 6–8 days (Cornelissen et al., 2008). A longer period after catheter implantation might decrease the post-surgical changes of the bladder; on the other hand, it might increase problems from mucosal regeneration, giving rise to obstruction of the catheter.

Conscious but restrained conditions allow accurate measurements without movement artifacts. In contrast to those in rats, few studies are described in mice and these have been mainly in spinal cord injury models (DePaul et al., 2015; Kadekawa et al., 2016). However, restraint appears to reduce the voided volumes to less than 50 ul (DePaul et al., 2015; Kadekawa et al., 2016). Thus, like anesthesia, restrained conditions might influence urodynamic function (see below).

Electromyography of the external urethral sphincter (Figure 2) can be combined with various techniques can be used for conscious restraint (Kadekawa et al., 2016) and decerebration (Sadananda et al., 2011, 2013).

Cystometry and EMG recordings from spinal cord intact (A) and T8–T9 spinal cord injury (SCI; B) mice 2 weeks post-injury with the brain rostral to the supracollicular level sectioned from the brainstem and removed. Transperineal recording of the external urethral sphincter is combined with conventional filling cystometry. (A-1): This shows the guarding reflex that prevents leaking as bladder pressure approaches threshold. This is followed by increased phasic (bursting) and decreased tonic activity during which voiding occurs and pressure returns to baseline. (B): Following transection and the development of detrusor-sphincter-dyssynergia (DSD; B-1), when the bladder contracts, tonic sphincter activity increases resulting in non-voiding contractions and eventually overflow incontinence.

 Filling cystometry (storage phase) Bladder

Parameters assessed during filling cystometry include bladder capacity, bladder compliance, the number of non-voiding contractions (NVCs), basal pressure (BP) at the initiation of filling and threshold pressure (TP) at onset of micturition. With mouse filling cystometry, the BP and TP are usually around 5—10 cmH2O (Pandita et al., 2000; Schröder et al., 2003, 2004; Igawa et al., 2004; Boudes et al., 2011; Aizawa et al., 2013) and 10–40 cmH2O (Pandita et al., 2000; Igawa et al., 2004; Schröder et al., 2004; Smith and Kuchel, 2010; Soler et al., 2010; Aizawa et al., 2013), respectively.

Filling rates used vary widely, from 10 (Cornelissen et al., 2008; Aizawa et al., 2013; Mingin et al., 2015) to 100 (Sutherland et al., 1997; Lemack et al., 2000; Jusuf et al., 2001) μl/min. With C57BL6 mice, filling rate in ambulatory filling cystometry seems to be most appropriate at 10 μl/min (Cornelissen et al., 2008; Aizawa et al., 2013; Mingin et al., 2015), because voided volumes are approximately 140–180 μl; similar to that in ambulatory frequency volume charts (Aizawa et al., 2013) (Table 3). The filling rate will affect LUT function. In urodynamic studies, ideally this should be close to the natural filling rate determined by the rate of urine production. However, this can be difficult to do in practize and will lead to long durations between voids. For example, young mice usually urinate around 10 times per day (Aizawa et al., 2013). Natural filling also makes it difficult to calculate the precise bladder infusion volume and is a significant limitation at this small bladder capacity. Thus, artificial filling is usually more practical and advantageous for maximizing urodynamic observations, notwithstanding that mice generally void with longer intervals.

Summary of invasive tests for mouse urodynamic studies.

Filling rate (μl/min) Species Sex Weeks Body weight (g) Urodynamic parameters
Voided volume per micturition (μl) Basal pressure Threshold pressure Micturition pressure Unit Reference
Conscious 10 C57BL/6J m 25 40.8 ± 2.0 146 ± 42 7.5 ± 2.8 18.6 ± 4.3 30.3 ± 4.0 cmH2O Aizawa et al., 2013
10 C57BL/6 m NA 20–30 140 ± 23.0 NA 17.9 ± 3.0 19.8 ± 1.8 mmHg Cornelissen et al., 2008
10 f NA 20–30 143 ± 28.0 NA 12.2 ± 2.5 19.3 ± 2.4
10 Balb/CAN m NA 20–30 30.3 ± 4.0 NA 25.5 ± 5.2 19.2 ± 2.8
10 f NA 20–30 40.5 ± 7.3 NA 18.1 ± 3.2 19.0 ± 2.5
10 A/J m NA 20–30 50.0 ± 4.3 NA 5.3 ± 6.3 17.2 ± 2.6
10 f NA 20–30 51.7 ± 8.4 NA 16.1 ± 3.5 18.4 ± 4.3
10 B6:129 m NA 20–30 164 ± 49.0 NA 16.9 ± 1.8 21.5 ± 3.0
10 f NA 20–30 184 ± 59.0 NA 13.9 ± 2.5 19.7 ± 2.7
10 129 m NA 20–30 50.2 ± 11.9 NA 14.4 ± 1.8 15.8 ± 2.3
10 f NA 20–30 77.5 ± 12.9 NA 10.8 ± 1.4 16.1 ± 1.8
41.7 WT (129/SvJ) m 18–23 NA 240 ± 20 7.1 ± 0.9 17.8 ± 1.4 32.3 ± 2.5 cmH2O Igawa et al., 2004
41.7 f 18–23 NA 170 ± 10 7.6 ± 0.7 18.8 ± 0.9 33.4 ± 2.4
10 C57BL/6 m 6 20–30 about 180 about 8 NA NA mmHg Mingin et al., 2015
25 Balb/CJ f NA 20.2 ± 0.4 110 ± 20 7.11 ± 1.0 12.12 ± 1.22 63.71 ± 5.21 cmH2O Pandita et al., 2000
25 WT (DBA/1LacJ) NA NA 17.2 ± 0.4 49.5 ± 7.6 6.3 ± 2.1 12.5 ± 2.2 36.0 ± 4.5 cmH2O Schröder et al., 2004
25 MNRI f NA 25.7 ± 0.4 150 ± 20 5.9 ± 1.3 9.5 ± 1.0 40.3 ± 3.3 cmH2O Schröder et al., 2003
25 C57BL/6J f NA 15–37 not obtained NA about 20 about 40 cmH2O Smith and Kuchel, 2010
33.3 WT (albino FVB) m 4–6 mo NA 200 ± 40 29.9 ± 7.0 42.2 ± 2.5 59.0 ± 5.4 cmH2O Soler et al., 2010
33.3 f 18 mo NA 170 ± 60 29.9 ± 2.0 47.3 ± 2.1 64.5 ± 15.7
15 WT (129Sv and C57BL/6J) f 12 24.3 ± 0.9 130 ± 10 NA NA 34.9 ± 1.6 mmHg Chen et al., 2005
Restrained 10 C57BL/6N f 9 18–20 50 ± 20 8.1 ± 1.3 NA 32.0 ± 5.0 cmH2O Kadekawa et al., 2016
25 C57BL/6 f 8–10 NA about 20 NA NA NA mmHg DePaul et al., 2015
Anesthesia 20 Balb/CAN m NA 18–22 58 ± 13 NA NA 12 ± 5 mmHg Beamon et al., 2009
13.3 129S1/SvImJ m 10–12 27.1 ± 0.8 123.6 NA NA 39 ± 1.4 mmHg Bjorling et al., 2015
13.3 f 10–12 21.8 ± 0.8 196.8 ± 28 NA NA 51.5 ± 2.4
13.3 C57BL/6J m 10–12 27.6 ± 0.5 42.0 NA NA 21.9 ± 1.5
13.3 f 10–12 19.2 ± 0.2 32 ± 2.7 NA NA 27.1 ± 1.2
13.3 NOD/ShiLtJ m 10–12 29.1 ± 1.3 90.0 NA NA 25 ± 1.8
13.3 f 10–12 24.5 ± 0.4 148 ± 18.7 NA NA 31.5 ± 2.3
13.3 CAST/EiJ m 10–12 16.6 ± 0.3 111.1 NA NA 25.4 ± 3.1
13.3 f 10–12 13.4 ± 0.6 77.3 ± 10.7 NA NA 22.8 ± 1.2
20 C57BL/6 m 10–12 NA 48 6.9 ± 0.5 4.2 ± 0.2 26.6 ± 1.0 cmH2O Boudes et al., 2011
25 Balb/CAN f NA 26.8 57.5 NA NA 26.8 ± 2.4 mmHg Comiter and Phull, 2012
100 WT (ICR and C57 strains) f 4–6 mo 32.3 260 ± 110 NA NA NA mmHg Lemack et al., 2000
25 C57BL/6 f 2 mo about 18 about 50 about 12 about 40 48 ± 2.5 cm/W Smith et al., 2012
25 12 mo about 26 about 100 about 8 about 30 47 ± 1.2
25 22 mo about 26 about 120 about 6 about 30 44 ± 1.7
25 26 mo about 30 about 200 about 4 about 25 44 ± 2.3
20 C57BL/6J f 11–13 NA about 80 about 3 NA about 40 cmH2O Franken et al., 2016
80 WT (FVB/N) m 4–9 mo 24.3–37.7 NA NA NA 25.6 ± 4.8 mmHg Streng et al., 2002a
80 WT (FVB/N) m 7–8 mo 30.6 ± 3.3 NA NA NA 28.5 ± 5.6 mmHg Streng et al., 2002b
10 WT (C57BL6) m 9–17 25.7 ± 1.1 about 200 NA NA NA cmH2O Birder et al., 2002
100 WT (129Sv and C57BL/6) f NA 18.7 420 ± 210 NA NA 59.5 ± 12.8 cmH2O Sutherland et al., 1997
25 C57BL/6J f NA 15–37 90 ± 20 NA about 40 about 60 cmH2O Smith and Kuchel, 2010
Decerebrated 10 WT (C57BL/6Cr) m 8–12 22.1 ± 0.3 131 ± 11 NA 3.8 ± 0.4 23.0 ± 2.2 mmHg Yoshiyama et al., 2015

f, female; m, male; NA, not assessed; mo, months; WT, wild type.

Of the range of available anesthesic agents, urethane is usually used in mouse cystometry (Sutherland et al., 1997; Jusuf et al., 2001; Birder et al., 2002; Smith and Kuchel, 2010; Boudes et al., 2011; Smith et al., 2012; Bjorling et al., 2015). Focusing on C57BL6 mice, Table 3 shows that the voided volume of conscious mice is 140–146 μl (Cornelissen et al., 2008; Aizawa et al., 2013), and those anesthetized with urethane is 32–90 μl (Smith and Kuchel, 2010; Boudes et al., 2011; Bjorling et al., 2015; Franken et al., 2016). These findings indicate that anesthesia might reduce the voided volume of mice during filling cystometry, although other experimental manipulations may confound this interpretation: For example anesthesia allows a stable trace to be recorded without artifact from physical activity (Smith and Kuchel, 2010; Boudes et al., 2011; Smith et al., 2012; Boudes et al., 2013; Yu et al., 2014; Bjorling et al., 2015; Franken et al., 2016). However, the effects of anesthetic agents on urodynamic parameters cannot be avoided. Urethane was reported to influence the voiding function of rodents less than other agents (Matsuura and Downie, 2000). However, some studies indicated that any form of anesthesia can affect the cystometric patterns of mice (Smith and Kuchel, 2010) in a similar way to rats (Yoshiyama et al., 1993a,b; Aizawa et al., 2015b). Some previous studies using rats indicated that urethane anesthesia can suppress the bladder micturition reflex and NVCs (Cheng and de Groat, 2004). Another study using a decerebrated rat model suggested that urethral activity, which is essential for efficient voiding, is more sensitive to the dose dependent suppressive effect of urethane than afferent or efferent mechanisms controlling the bladder. Furthermore, the afferent limb had a higher sensitivity to urethane than the efferent limb in the micturition reflex pathway. Because effects of urethane persisted after removal of the forebrain, they were presumed to be mediated by actions on the brain stem, spinal cord, or peripheral nervous system (Yoshiyama et al., 2013).

NVC activity has been observed in both awake and anesthetized mice (Pandita et al., 2000; Birder et al., 2002; Cornelissen et al., 2008; Comiter and Phull, 2012; Smith et al., 2012; Mingin et al., 2015; Yoshiyama et al., 2015). It has been proposed that this activity contributes to the volume sensory process, via activation of mechanoreceptors during filling (Lagou et al., 2006b; Streng et al., 2006). NVCs are described as phasic increases of intravesical pressure during filling cystometry, not associated with passage of urine. For precise confirmation of NVC, it is necessary to confirm there is no urine expulsion from the urethra when NVC activity is documented in the bladder pressure recordings. Many previous reports have used a minimum amplitude for NVCs of 5–10 mmHg (Birder et al., 2002; Cornelissen et al., 2008; Comiter and Phull, 2012; Yoshiyama et al., 2015; Kadekawa et al., 2016). However, there are no reliable and well-acceptable diagnostic criteria to define NVCs, which leads to variation of NVC parameters between studies (Pandita et al., 2000; Birder et al., 2002; Cornelissen et al., 2008; Comiter and Phull, 2012; Smith et al., 2012; Mingin et al., 2015; Yoshiyama et al., 2015; Kadekawa et al., 2016).

 Outlet

The functional examination of the urethral sphincter is difficult in mouse urodynamic studies. Electromyography (EMG) of the external urethral sphincter (EUS) is technically challenging because of their small size (Andersson et al., 2011). Therefore, co-ordinated activity of bladder and urethra under normal and pathological conditions has not been well-characterized in mice, in contrast to numerous studies in rats (Sadananda et al., 2011). There are a few reports that measure the EUS-EMG in the awake mice under restrained conditions. In these, fine wire EMG electrodes were placed percutaneously into or near the EUS and simultaneous measurements of intravesical pressure and EUS-EMG activity were performed during continuous cystometrograms (DePaul et al., 2015; Kadekawa et al., 2016). These reports showed low-amplitude tonic EUS-EMG activity between voids during continuous infusion (DePaul et al., 2015). However, they mainly focused on EUS-EMG activity during the voiding phase, so the specific details during the storage phase is still incompletely described (DePaul et al., 2015; Kadekawa et al., 2016).

 Sensory function during filling

To investigate afferent pathways from the bladder, direct measurement of afferent nerve activity is necessary and pelvic nerve activity is most often measured. Afferent nerve activity of mice has mainly been measured with in vitro experiments (Daly et al., 2007, 2010, 2014; Collins et al., 2013; Mingin et al., 2015) and in vivo observations are fewer (Zvara et al., 2010) as in vivo measurement is technically difficult. The above studies were performed to investigate the afferent activity during bladder filling, not during the voiding phase as these preparations were not voiding. With ex vivo experiments, the urinary bladder and urethra were usually dissected with postganglionic nerves, major pelvic ganglia, and pelvic nerves and placed in a recording chamber recirculated with gassed (95% O2 and 5% CO2) saline solution at 35 (Daly et al., 2007, 2010, 2014; Collins et al., 2013) or 37 (Mingin et al., 2015) °C. Subsequently, the pelvic nerves were teased into fine branches and placed onto platinum electrodes for recording.

During the storage phase, ramp bladder distension caused an increase in afferent discharge with increasing intravesical pressure (Daly et al., 2007, 2010, 2014; Collins et al., 2013; Mingin et al., 2015). The relationship between afferent discharge and pressure is non-linear. Afferent activity increases markedly when intraluminal pressure is raised between 0 and 20 mmHg, with a smaller increase as intraluminal pressure is further raised between 20 and 45 mmHg) (Daly et al., 2007).

In general, direct measurement of pelvic nerve activity records afferent activity from many units, that includes neurones innervating not only the bladder, but also the urethra and other pelvic organs such as the rectum. To overcome this problem, single-unit mechanosensitive afferent measurement in vivo (Aizawa et al., 2012, 2014, 2015a) and ex vivo (Ito et al., 2016) in a rat model has been developed and were able to distinguish between A-delta and C fibers. To date the same approach has not been reported for mouse preparations.

 Pressure flow studies (voiding phase) Bladder

Pressure flow studies are used to assess several urodynamic parameters, including maximum detrusor pressure (Pdet max), maximum flow rate (Qmax), detrusor pressure at maximum flow rate; (Pdet Qmax), high frequency oscillations of Pdet and post voided residual volume.

The small voided volume of mice makes difficult the precise time-dependent correlation of Pdet changes and urine flow rate in a pressure-flow study. However, some studies have estimated flow rate during voiding, for example, for example by dividing total voided volume by total flow to obtain average urine flow rate (Smith et al., 2012). Urine flow rate has also been measured with an ultrasonic flow probe surrounding the distal urethra between the rhabdosphincter and penile bulb and connected to a flow meter (Streng et al., 2002a,b). These studies indicated that the maximum urine flow rate of mice was 16.8–17.7 and the average was 1–2.5 ml/min (Streng et al., 2002a,b; Smith et al., 2012).

In mice, the measurement of residual urine volume is also technically challenging, but some studies report values of 2–60 μl in normal conscious mice during urodynamic testing (Pandita et al., 2000; Schröder et al., 2003; Igawa et al., 2004; Chen et al., 2005; Soler et al., 2010). In attempting to measure precise residual urine volume in mice, a single cycle cystometry technique may be employed, where the bladder is emptied by aspiration after voiding. This technique may allow residual urine volume to be measured directly.

Finally, the voiding pressure of mice anesthetized with urethane is significantly higher than that of mice without anesthesia (Smith and Kuchel, 2010). To our knowledge, the effects of anesthesia on residual urine volume has not been measured thus far, but in rats, urethane, and chloral hydrate anesthesia led to less efficient voiding and increased residual urine volume (Streng et al., 2006).

 Outlet

Technical challenges with flow measurement mean that assessment of voiding in mice is based on the observation of urine output and increased bladder pressure. However, this has the limitation that co-ordinated voiding driven by the pontine micturition center (PMC) cannot be distinguished from non-voiding urine flow (leakage of urine equivalent to detrusor overactivity incontinence).

Mouse cystometric studies have observed intravesical pressure oscillations that accompany urine flow, attributed to high frequency opening and closing of the urethra. This characterization is not seen in other species, except rats (Streng et al., 2002a,b). At the onset of the voiding contraction, the EUS-EMG activity increases in amplitude and shows “bursting” coincident with rapid intravesical pressure oscillations in the cystometric tracing. Subsequently EUS-EMG activity declines after the peak of the contraction coinciding with the void (DePaul et al., 2015). In clinical urodynamics, such an intravesical pressure oscillations with concomitant involuntary urethral sphincter activation implies detrusor sphincter dyssynergia (DSD), as seen in upper spinal or brainstem neurological conditions, such as spinal cord injury or multiple sclerosis.

However, the details of EUS function during bladder contraction is still unclear in mice. EUS-EMG recordings are better-characterized in rats, and exhibit tonic activity before the onset of voiding and bursting activity during voiding, which generates high frequency pressure oscillations. Here a subsequent post-void pressure increase occurs as the bladder remains contracted whilst the EUS ceases bursting and resumes tonic firing (Sadananda et al., 2011, 2013).

 Sensory function during voiding

There are no published reports of afferent activity measurement during the voiding phase. Pressure-flow studies using a decerebrated arterially-perfused rat show characteristic pelvic nerve recordings during the voiding phase, with bursts of activity corresponding to changes in bladder pressure and EUS activity (Sadananda et al., 2011).

 Special tests Sensation

To date, there are no reports in mice characterizing sensations during the micturition cycle. To know how a mouse senses such activity is not possible (Parsons and Drake, 2011), however functional brain imaging might give a surrogate indication. In rats, there are some functional brain imaging studies using techniques such as functional magnetic resonance imaging (fMRI) and positron emission tomography (PET). These have identified brain regions activated during bladder filling and voluntary control of micturition (Tai et al., 2009; Deruyver et al., 2015; Wong et al., 2015). During storage, the periaqueductal gray (PAG) is activated by afferent input from the urinary bladder, whilst the PMC is inactive (Tai et al., 2009). Storage is also accompanied by activation of several regions including the motor cortex, somatosensory cortex, cingulate cortex, retrosplenial cortex, thalamus, putamen, insula, and the septal nucleus (Tai et al., 2009).

These techniques have also identified in rats brain regions activated during bladder contractions (Tai et al., 2009; Deruyver et al., 2015; Wong et al., 2015). When bladder volume increased to the micturition threshold, the switch from storage to micturition was associated with PMC activation and enhanced PAG activity (Tai et al., 2009). Micturition was also associated with increased activity of several regions including: The motor cortex, thalamus, putamen, cingulate, insula, hypothalamus, substantia nigra, globus pallidus, hippocampus, and inferior colliculus (Tai et al., 2009). A small-animal PET imaging study demonstrated that volume-induced voiding and isovolumetric bladder contractions in rats provoke changes in brain metabolism, including activation of the insular and cingulate cortices, which is consistent with their proposed role in mapping bladder afferent activity (Deruyver et al., 2015). However, knowledge of the precise functions these various regions play in the micturition remains unclear.

 Proxies for disease conditions

A large range of mouse models has contributed to the understanding of pathophysiologies underlying LUTS (Parsons and Drake, 2011). Most are animal models with induced dysfunction, in which relevant pathological changes are experimentally applied to a healthy animal. In addtion, genetically modified mouse models, for instance transgenic mice, have been used to investigate functional urological changes. In this section, we review currently available pathophysiological mouse models and describe their use and also their limitations when interpreting results from animal models to understand human conditions.

Sensory stimulation models

Animal models of OAB and bladder pain syndrome (BPS) are commonly made by eliciting bladder hypersensitivity and/or inflammation, which is chemically induced by intravesical or intraperitoneal instillation of a noxious substance (Parsons and Drake, 2011). Chemical agents used for this purpose include cyclophosphamide (Boudes et al., 2013), acetic acid (Yoshiyama et al., 2008, 2010), or hydrogen peroxide (Homan et al., 2013; Dogishi et al., 2015).

OAB is a symptom-based diagnosis, so it is currently impossible to develop a true animal model for OAB (Parsons and Drake, 2011). BPS has an important symptomatic element, but there are additional structural changes which could potentially be modeled (Offiah et al., 2016). For example, recent papers indicate that Hunner-type interstitial cystitis shows histologically obvious inflammation (Maeda et al., 2015; Akiyama et al., 2016). An experimental autoimmune cystitis model induced by uroplakin 3A-derived immunogenic peptide might be a possible BPS model in mice. This model showed autoimmune inflammatory changes of the bladder, and key phenotype features (Izgi et al., 2013).

 Reduced compliance models

Spinal cord injury (SCI) models are one of the commonest neurological models used. With SCI models using mice, complete transection of the thoracic spinal cord at vertebral level T8 (DePaul et al., 2015), T8/9 (McCarthy et al., 2009; Kadekawa et al., 2016), or T10 (Wilson et al., 2005) have been reported. The timing of measurements after development of SCI vary substantially from study to study—from 1–2 weeks (McCarthy et al., 2009), 1–6 weeks (Wilson et al., 2005), 4 weeks (Kadekawa et al., 2016), up to 18 weeks (DePaul et al., 2015). SCI is associated with increased bladder weight [2.3 times (Wilson et al., 2005) larger than that of controls]. Cystometric changes after SCI show increased numbers of NVCs (McCarthy et al., 2009; Kadekawa et al., 2016), decreased voiding efficiency (Kadekawa et al., 2016), and increased residual urine volume (DePaul et al., 2015; Kadekawa et al., 2016). The combination of pressure-flow studies and EMG measurements in mice with SCI indicate development of DSD (DePaul et al., 2015) and decreased EUS activity (Kadekawa et al., 2016).

Mice with experimental autoimmune encephalomyelitis have been used to study neuro-inflammatory bladder dysfunction equivalent to that which occurs with multiple sclerosis, and showed detrusor overactivity in severe experimental autoimmune encephalomyelitis (Franken et al., 2016). Extrapolating data from these models has to take into account the uncertainties of transferring findings from an acute model to a chronic human condition. Experimental autoimmune encephalomyelitis is also a transient self-limiting condition that often recovers spontaneously, whereas multiple sclerosis is chronic and progressive.

 Bladder outlet obstruction (BOO) models

Effects similar to BOO in humans are apparently straightforward to model in animals. This has been achieved by partial obstruction of the urethra using some form of ligature. The time to when measurements are made after development of BOO vary from study to study—from 1 week (Schröder et al., 2003), 4 weeks (Austin et al., 2004), 5 weeks (Pandita et al., 2000) up to 6 weeks (Beamon et al., 2009; Comiter and Phull, 2012) following BOO surgery. These mouse models show many of the structural and physiological bladder wall changes seen in human BOO, including muscle cell hypertrophy (Austin et al., 2004; Beamon et al., 2009; Comiter and Phull, 2012), altered responsiveness to stimuli (Austin et al., 2004), and altered spontaneous myogenic activity (Beamon et al., 2009) with enhancement of NVCs (Pandita et al., 2000; Comiter and Phull, 2012).

Many of the published studies using partial BOO murine models have used female mice (Pandita et al., 2000; Schröder et al., 2003; Comiter and Phull, 2012), which complicates their interpretation, given that they are derived to model male benign prostatic hyperplasia (BPH). Furthermore, induced BOO is much more acute and potentially more severe than BPH–particularly if the urethra is ligated by a suture tied firmly against a rigid rod. BOO models showed increased bladder weight 2.5–3.9 times (Pandita et al., 2000; Austin et al., 2004; Beamon et al., 2009; Comiter and Phull, 2012) larger than that of control. BOO murine models may involve not only outlet obstruction but also detrusor insufficiency but no urodynamic features to distinguish have been agreed. Notwithstanding, partial BOO appears to be a good model to study LUTS as it can be reliably reproduced.

 Transgenic models

Knock-out (KO) models and other transgenic animals are used to study and understand the molecular mechanisms involved in both normal LUT physiology and dysfunction. The mouse is most commonly employed, given that it is widely available, easy to maintain and has a relatively short generation interval.

Several transgenic mouse models have been studied in the functional urological field and urodynamic studies have been performed in mice with KO of; alpha−1D receptors (Chen et al., 2005), muscarinic, M2 and M3 receptors (Igawa et al., 2004), purinergic receptor (P2X3) (Cockayne et al., 2000), EP1 receptors (Schröder et al., 2004), TRPV1 and TRPV4 channels (Birder et al., 2002; Yoshiyama et al., 2015), neuronal nitric oxide synthase (nNOS) (Sutherland et al., 1997), inducible nitric oxide synthase (iNOS) (Lemack et al., 2000), uroplakin II (UPII) and III (UPIIIa) (Aboushwareb et al., 2009), Ncx/Hox11L.1 (a member of the Hox11 homeobox gene family) (Jusuf et al., 2001). Studies have also described Immp2lTg(Tyr)979Ove mutant mice with mitochondrial dysfunction which have a deficiency of Immp2l protein (Soler et al., 2010), and aromatase overexpressing transgenic mice (Streng et al., 2002a,b). Specific urodynamic features seen in these mice, which informed the phenotype and pathophysiological understanding have been reviewed elsewhere (Parsons and Drake, 2011).

 Aging models

An appropriate study to clarify the pathophysiology of aging is needed but there are many limitations to performing such an investigation. In the elderly human population there are important indirect interactions due to comorbidities such as hypertension, diabetes mellitus, hyperlipidemia, and cerebrovascular or cardiovascular diseases. It is also difficult to separate the influence of such disorders from that of aging. In rodent models, the influence of at least some of these comorbidities can be avoided though they are rarely evaluated and reported. The age of mice used for aging studies has varied from 12 months (Lai et al., 2007), 70 weeks (Shenfeld et al., 2005), 20 months (Perše et al., 2013), 22 months (Smith et al., 2012), 18–24 months (Lagou et al., 2006a), 24 months (Daly et al., 2014), 26 months (Smith et al., 2012), and 28–34 months (Lagou et al., 2006b).

To our knowledge, there is only one study that investigated age-related changes to mice cystometric parameters (Smith et al., 2012). This showed that aging (26 months) is associated with an impaired ability to respond to the challenge of continuous bladder filling with cyclic voiding and diminished bladder volume sensitivity (Smith et al., 2012).

In addition, organ bath studies using isolated mice bladder show that both micromotion related activity and the phasic component of the contractile response to muscarinic agonists are substantially reduced in aging mice (Lagou et al., 2006b). Another immunohistochemical analysis showed that older mice showed patchy denervation of the detrusor (Lagou et al., 2006a).

 Other models

Mingin and colleagues demonstrated that some social stress decreased voided volume in young male mice, and they proposed this approach as an overactivity model by social stress (Mingin et al., 2015). Acute exposure of part of the skin to cold stimuli can also evoke rapid bladder contractions and voids in anesthetized mice and was proposed as an acute cold-induced urgency model (Uvin et al., 2015). These models lead to increased sensory activity, which is a mechanism that has been proposed as a potential cause of urgency.

 Conclusions

Animal experiments are fundamental for understanding LUT function and these experiments also contribute to investigation of pathophysiological changes. Rats are currently the most used animal model for neuro-urodynamic studies, and mouse urodynamics has not been so well-characterized. However, the mouse models available, notably genetic modifications, provide valuable mechanistic insights. The present review covers recent knowledge of mouse urodynamics and considers potential implications in the clinical field. However, there are some differences between mouse and human urodynamics which must be considered when neuro-urodynamics to interpret voiding in mice models. Available disease models in mice have crucial issues of interpretation when deriving translational value. Nonetheless, mouse urodynamic tests should give important information on bladder physiology, pathophysiology and pharmacology.

 Author contributions

Substantial contributions to the conception or design of the work; HI, AP, YI, AK, CF, and MD. The acquisition of the data; HI, YI, and AK. The analysis, or interpretation of data for the work; HI, AP, YI, AK, CF, and MD. Drafting the work or revising it critically for important intellectual content; HI, AP, YI, AK, CF, and MD. Final approval of the version to be published; HI, AP, YI, AK, CF, and MD. Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved; HI, AP, YI, AK, CF, and MD.

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Funding is through United States National Institutes of Health grant NIH R01 DK098361 (AK, MD, CF, AP)

 References Aboushwareb T. Zhou G. Deng F. M. Turner C. Andersson K. E. Tar M. . (2009). Alterations in bladder function associated with urothelial defects in uroplakin II and IIIa knockout mice. Neurourol. Urodyn. 28, 1028–1033. 10.1002/nau.2068819267388 Aizawa N. Hedlund P. Füllhase C. Ito H. Homma Y. Igawa Y. (2014). Inhibition of peripheral FAAH depresses activities of bladder mechanosensitive nerve fibers of the rat. J. Urol. 192, 956–963. 10.1016/j.juro.2014.04.00824746881 Aizawa N. Homma Y. Igawa Y. (2012). Effects of mirabegron, a novel beta3-adrenoceptor agonist, on primary bladder afferent activity and bladder microcontractions in rats compared with the effects of oxybutynin. Eur. Urol. 62, 1165–1173. 10.1016/j.eururo.2012.08.05622981677 Aizawa N. Homma Y. Igawa Y. (2013). Influence of high fat diet feeding for 20 weeks on lower urinary tract function in mice. Low. Urin. Tract Symptoms 5, 101–108. 10.1111/j.1757-5672.2012.00172.x26663378 Aizawa N. Ito H. Sugiyama R. Fujimura T. Suzuki M. Fukuhara H. . (2015a). Selective inhibitory effect of imidafenacin and 5-hydroxymethyl tolterodine on capsaicin sensitive C fibers of the primary bladder mechanosensitive afferent nerves in the rat. J. Urol. 193, 1423–1432. 10.1016/j.juro.2014.09.00525219701 Aizawa N. Ogawa S. Sugiyama R. Homma Y. Igawa Y. (2015b). Influence of urethane-anesthesia on the effect of resiniferatoxin treatment on bladder function in rats with spinal cord injury. Neurourol. Urodyn. 34, 274–279. 10.1002/nau.2254924375785 Akiyama Y. Morikawa T. Maeda D. Shintani Y. Niimi A. Nomiya A. . (2016). Increased CXCR3 Expression of infiltrating plasma cells in hunner type interstitial cystitis. Sci. Rep. 6:28652. 10.1038/srep2865227339056 Andersson K. E. Soler R. Füllhase C. (2011). Rodent models for urodynamic investigation. Neurourol. Urodyn. 30, 636–646. 10.1002/nau.2110821661007 Arakawa H. Blanchard D. C. Arakawa K. Dunlap C. Blanchard R. J. (2008). Scent marking behavior as an odorant communication in mice. Neurosci. Biobehav. Rev. 32, 1236–1248. 10.1016/j.neubiorev.2008.05.01218565582 Austin J. C. Chacko S. K. DiSanto M. Canning D. A. Zderic S. A. (2004). A male murine model of partial bladder outlet obstruction reveals changes in detrusor morphology, contractility and Myosin isoform expression. J. Urol. 172(4 Pt 1), 1524–1528. 10.1097/01.ju.0000138045.61378.9615371884 Beamon C. R. Mazar C. Salkini M. W. Phull H. S. Comiter C. V. (2009). The effect of sildenafil citrate on bladder outlet obstruction: a mouse model. BJU Int. 104, 252–256. 10.1111/j.1464-410X.2008.08324.x19154466 Birder L. A. Nakamura Y. Kiss S. Nealen M. L. Barrick S. Kanai A. J. . (2002). Altered urinary bladder function in mice lacking the vanilloid receptor TRPV1. Nat. Neurosci. 5, 856–860. 10.1038/nn90212161756 Bjorling D. E. Wang Z. Vezina C. M. Ricke W. A. Keil K. P. Yu W. . (2015). Evaluation of voiding assays in mice: impact of genetic strains and sex. Am. J. Physiol. Renal Physiol. 308, F1369–F1378. 10.1152/ajprenal.00072.201525904700 Boudes M. Uvin P. Kerselaers S. Vennekens R. Voets T. De Ridder D. (2011). Functional characterization of a chronic cyclophosphamide-induced overactive bladder model in mice. Neurourol. Urodyn. 30, 1659–1665. 10.1002/nau.2118021717507 Boudes M. Uvin P. Pinto S. Voets T. Fowler C. J. Wenning G. K. . (2013). Bladder dysfunction in a transgenic mouse model of multiple system atrophy. Mov. Disord. 28, 347–355. 10.1002/mds.2533623426727 Chen Q. Takahashi S. Zhong S. Hosoda C. Zheng H. Y. Ogushi T. . (2005). Function of the lower urinary tract in mice lacking alpha1d-adrenoceptor. J. Urol. 174, 370–374. 10.1097/01.ju.0000161210.17365.cc15947692 Cheng C. L. de Groat W. C. (2004). The role of capsaicin-sensitive afferent fibers in the lower urinary tract dysfunction induced by chronic spinal cord injury in rats. Exp. Neurol. 187, 445–454. 10.1016/j.expneurol.2004.02.01415144870 Cockayne D. A. Hamilton S. G. Zhu Q. M. Dunn P. M. Zhong Y. Novakovic S. . (2000). Urinary bladder hyporeflexia and reduced pain-related behaviour in P2X3-deficient mice. Nature 407, 1011–1015. 10.1038/3503951911069181 Collins V. M. Daly D. M. Liaskos M. McKay N. G. Sellers D. Chapple C. . (2013). OnabotulinumtoxinA significantly attenuates bladder afferent nerve firing and inhibits ATP release from the urothelium. BJU Int. 112, 1018–1026. 10.1111/bju.1226623937318 Comiter C. Phull H. S. (2012). Angiotensin II type 1 (AT-1) receptor inhibition partially prevents the urodynamic and detrusor changes associated with bladder outlet obstruction: a mouse model. BJU Int. 109, 1841–1846. 10.1111/j.1464-410X.2011.10580.x21939491 Cornelissen L. L. Misajet B. Brooks D. P. Hicks A. (2008). Influence of genetic background and gender on bladder function in the mouse. Auton. Neurosci. 140, 53–58. 10.1016/j.autneu.2008.04.00118495551 Daly D. M. Chess-Williams R. Chapple C. Grundy D. (2010). The inhibitory role of acetylcholine and muscarinic receptors in bladder afferent activity. Eur. Urol. 58, 22–28; discussion 31–22. 10.1016/j.eururo.2009.12.03020071074 Daly D. M. Nocchi L. Liaskos M. McKay N. G. Chapple C. Grundy D. (2014). Age-related changes in afferent pathways and urothelial function in the male mouse bladder. J. Physiol. 592, 537–549. 10.1113/jphysiol.2013.26263424297847 Daly D. Rong W. Chess-Williams R. Chapple C. Grundy D. (2007). Bladder afferent sensitivity in wild-type and TRPV1 knockout mice. J. Physiol. 583(Pt 2), 663–674. 10.1113/jphysiol.2007.13914717627983 de Groat W. C. Araki I. Vizzard M. A. Yoshiyama M. Yoshimura N. Sugaya K. . (1998). Developmental and injury induced plasticity in the micturition reflex pathway. Behav. Brain Res. 92, 127–140. 9638955 DePaul M. A. Lin C. Y. Silver J. Lee Y. S. (2015). Peripheral nerve transplantation combined with acidic fibroblast growth factor and chondroitinase induces regeneration and improves urinary function in complete spinal cord transected adult mice. PLoS ONE 10:e0139335. 10.1371/journal.pone.013933526426529 Deruyver Y. Rietjens R. Franken J. Pinto S. Van Santvoort A. Casteels C. . (2015). (18F)FDG-PET brain imaging during the micturition cycle in rats detects regions involved in bladder afferent signalling. EJNMMI Res. 5, 55. 10.1186/s13550-015-0132-026467154 Dogishi K. Kodera M. Oyama S. Shirakawa H. Nakagawa T. Kaneko S. (2015). Long-lasting pain-related behaviors in mouse chronic cystitis model induced by a single intravesical injection of hydrogen peroxide. J. Pharmacol. Sci. 129, 244–246. 10.1016/j.jphs.2015.11.00326685753 Drake M. J. Lewis A. L. Lane J. A. (2016). Urodynamic testing for men with voiding symptoms considering interventional therapy: the merits of a properly constructed randomised trial. Eur. Urol. 69, 759–760. 10.1016/j.eururo.2016.01.03526847139 Franken J. Gevaert T. Uvin P. Wauterickx K. Boeve A. C. Rietjens R. . (2016). Urodynamic changes in mice with experimental autoimmune encephalomyelitis correlate with neurological impairment. Neurourol. Urodyn. 35, 450–456. 10.1002/nau.2274225727376 Fry C. H. Daneshgari F. Thor K. Drake M. Eccles R. Kanai A. J. . (2010). Animal models and their use in understanding lower urinary tract dysfunction. Neurourol. Urodyn. 29, 603–608. 10.1002/nau.2090320432320 Homan T. Tsuzuki T. Dogishi K. Shirakawa H. Oyama T. Nakagawa T. . (2013). A novel mouse model of chronic inflammatory and overactive bladder by a single intravesical injection of hydrogen peroxide. J. Pharmacol. Sci. 121, 327–337. 10.1254/jphs.12265FP23545478 Hou X. H. Hyun M. Taranda J. Huang K. W. Todd E. Feng D. . (2016). Central control circuit for context-dependent micturition. Cell 167, 73 e12–86 e12. 10.1016/j.cell.2016.08.07327662084 Igawa Y. Zhang X. Nishizawa O. Umeda M. Iwata A. Taketo M. . (2004). Cystometric findings in mice lacking muscarinic M2 or M3 receptors. J. Urol. 172, 2460–2464. 10.1097/01.ju.0000138054.77785.4a15538291 Ito H. Aizawa N. Fujita Y. Suzuki M. Fukuhara H. Homma Y. . (2015). Long-term caloric restriction in rats may prevent age related impairment of in vitro bladder function. J. Urol. 193, 2123–2130. 10.1016/j.juro.2014.11.00525451828 Ito H. Aizawa N. Sugiyama R. Watanabe S. Takahashi N. Tajimi M. . (2016). Functional role of the transient receptor potential melastatin 8 (TRPM8) ion channel in the urinary bladder assessed by conscious cystometry and ex vivo measurements of single-unit mechanosensitive bladder afferent activities in the rat. BJU Int. 117, 484–494. 10.1111/bju.1322526189966 Izgi K. Altuntas C. Z. Bicer F. Ozer A. Sakalar C. Li X. . (2013). Uroplakin peptide-specific autoimmunity initiates interstitial cystitis/painful bladder syndrome in mice. PLoS ONE 8:e72067. 10.1371/journal.pone.007206723977210 Jusuf A. A. Kojima S. Matsuo M. Tokuhisa T. Hatano M. (2001). Vesicourethral sphincter dysfunction in ncx deficient mice with an increased neuronal cell number in vesical ganglia. J. Urol. 165, 993–998. 10.1016/S0022-5347(05)66590-111176528 Kadekawa K. Yoshimura N. Majima T. Wada N. Shimizu T. Birder L. A. . (2016). Characterization of bladder and external urethral activity in mice with or without spinal cord injury-a comparison study with rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 310, R752–R758. 10.1152/ajpregu.00450.201526818058 Lagou M. De Vente J. Kirkwood T. B. Hedlund P. Andersson K. E. Gillespie J. I. . (2006a). Location of interstitial cells and neurotransmitters in the mouse bladder. BJU Int. 97, 1332–1337. 10.1111/j.1464-410X.2006.06203.x16686734 Lagou M. Gillespie J. Kirkwood T. Harvey I. Drake M. J. (2006b). Muscarinic stimulation of the mouse isolated whole bladder: physiological responses in young and ageing mice. Auton. Autacoid Pharmacol. 26, 253–260. 10.1111/j.1474-8673.2006.00364.x16879490 Lai H. H. Boone T. B. Thompson T. C. Smith C. P. Somogyi G. T. (2007). Using caveolin-1 knockout mouse to study impaired detrusor contractility and disrupted muscarinic activity in the aging bladder. Urology 69, 407–411. 10.1016/j.urology.2006.12.01817320698 Lemack G. E. Zimmern P. E. Vazquez D. Connell J. D. Lin V. K. (2000). Altered response to partial bladder outlet obstruction in mice lacking inducible nitric oxide synthase. J. Urol. 163, 1981–1987. 10.1016/S0022-5347(05)67614-810799243 Maeda D. Akiyama Y. Morikawa T. Kunita A. Ota Y. Katoh H. . (2015). Hunner-type (classic) interstitial cystitis: a distinct inflammatory disorder characterized by pancystitis, with frequent expansion of clonal B-cells and epithelial denudation. PLoS ONE 10:e0143316. 10.1371/journal.pone.014331626587589 Matsuura S. Downie J. W. (2000). Effect of anesthetics on reflex micturition in the chronic cannula-implanted rat. Neurourol. Urodyn. 19, 87–99. 10.1002/(SICI)1520-6777(2000)19:1<87::AID-NAU9>3.0.CO;2-O10602250 McCarthy C. J. Zabbarova I. V. Brumovsky P. R. Roppolo J. R. Gebhart G. F. Kanai A. J. (2009). Spontaneous contractions evoke afferent nerve firing in mouse bladders with detrusor overactivity. J. Urol. 181, 1459–1466. 10.1016/j.juro.2008.10.13919157431 Mingin G. C. Heppner T. J. Tykocki N. R. Erickson C. S. Vizzard M. A. Nelson M. T. (2015). Social stress in mice induces urinary bladder overactivity and increases TRPV1 channel-dependent afferent nerve activity. Am. J. Physiol. Regul. Integr. Comp. Physiol. 309, R629–R638. 10.1152/ajpregu.00013.201526224686 Negoro H. Kanematsu A. Doi M. Suadicani S. O. Matsuo M. Imamura M. . (2012). Involvement of urinary bladder Connexin43 and the circadian clock in coordination of diurnal micturition rhythm. Nat. Commun. 3, 809. 10.1038/ncomms181222549838 Offiah I. Didangelos A. Dawes J. Cartwright R. Khullar V. Bradbury E. J. . (2016). The expression of inflammatory mediators in bladder pain syndrome. Eur. Urol. 70, 283–290. 10.1016/j.eururo.2016.02.05826965559 Pandita R. K. Fujiwara M. Alm P. Andersson K. E. (2000). Cystometric evaluation of bladder function in non-anesthetized mice with and without bladder outlet obstruction. J. Urol. 164, 1385–1389. 10.1016/S0022-5347(05)67204-710992420 Parsons B. A. Drake M. J. (2011). Animal models in overactive bladder research. Handb. Exp. Pharmacol. 202, 15–43. 10.1007/978-3-642-16499-6_221290220 Perše M. Injac R. Erman A. (2013). Oxidative status and lipofuscin accumulation in urothelial cells of bladder in aging mice. PLoS ONE 8:e59638. 10.1371/journal.pone.005963823527235 Sadananda P. Drake M. J. Paton J. F. Pickering A. E. (2011). An exploration of the control of micturition using a novel in situ arterially perfused rat preparation. Front. Neurosci. 5:62. 10.3389/fnins.2011.0006221625609 Sadananda P. Drake M. J. Paton J. F. Pickering A. E. (2013). A functional analysis of the influence of beta3-adrenoceptors on the rat micturition cycle. J. Pharmacol. Exp. Ther. 347, 506–515. 10.1124/jpet.113.20734024008334 Schröder A. Newgreen D. Andersson K. E. (2004). Detrusor responses to prostaglandin E2 and bladder outlet obstruction in wild-type and Ep1 receptor knockout mice. J. Urol. 172, 1166–1170. 10.1097/01.ju.0000134186.58854.2c15311063 Schröder A. Uvelius B. Newgreen D. Andersson K. E. (2003). Bladder overactivity in mice after 1 week of outlet obstruction. Mainly afferent dysfunction? J. Urol. 170, 1017–1021. 10.1097/01.ju.0000070926.39442.4c12913762 Shenfeld O. Z. Meir K. S. Yutkin V. Gofrit O. N. Landau E. H. Pode D. (2005). Do atherosclerosis and chronic bladder ischemia really play a role in detrusor dysfunction of old age? Urology 65, 181–184. 10.1016/j.urology.2004.08.05515667900 Smith P. P. DeAngelis A. Kuchel G. A. (2012). Detrusor expulsive strength is preserved, but responsiveness to bladder filling and urinary sensitivity is diminished in the aging mouse. Am. J. Physiol. Regul. Integr. Comp. Physiol. 302, R577–R586. 10.1152/ajpregu.00508.201122204955 Smith P. P. Kuchel G. A. (2010). Continuous uroflow cystometry in the urethane-anesthetized mouse. Neurourol. Urodyn. 29, 1344–1349. 10.1002/nau.2085020127833 Soler R. Füllhase C. Lu B. Bishop C. E. Andersson K. E. (2010). Bladder dysfunction in a new mutant mouse model with increased superoxide–lack of nitric oxide? J. Urol. 183, 780–785. 10.1016/j.juro.2009.09.07420022053 Streng T. Hedlund P. Talo A. Andersson K. E. Gillespie J. I. (2006). Phasic non-micturition contractions in the bladder of the anaesthetized and awake rat. BJU Int. 97, 1094–1101. 10.1111/j.1464-410X.2006.06137.x16643498 Streng T. Lehtoranta M. Poutanen M. Talo A. Lammintausta R. Santti R. (2002a). Developmental, estrogen induced infravesical obstruction is reversible in adult male rodents. J. Urol. 168, 2263–2268. 10.1097/01.ju.0000034141.56909.2712394772 Streng T. Li X. Lehtoranta M. Mäkelä S. Poutanen M. Talo A. . (2002b). Infravesical obstruction in aromatase over expressing transgenic male mice with increased ratio of serum estrogen-to-androgen concentration. J. Urol. 168, 298–302. 10.1016/S0022-5347(05)64911-712050560 Sugino Y. Kanematsu A. Hayashi Y. Haga H. Yoshimura N. Yoshimura K. . (2008). Voided stain on paper method for analysis of mouse urination. Neurourol. Urodyn. 27, 548–552. 10.1002/nau.2055218551561 Sutherland R. S. Kogan B. A. Piechota H. J. Bredt D. S. (1997). Vesicourethral function in mice with genetic disruption of neuronal nitric oxide synthase. J. Urol. 157, 1109–1116. 9072553 Tai C. Wang J. Jin T. Wang P. Kim S. G. Roppolo J. R. . (2009). Brain switch for reflex micturition control detected by FMRI in rats. J. Neurophysiol. 102, 2719–2730. 10.1152/jn.00700.200919741099 Uvin P. Everaerts W. Pinto S. Alpizar Y. A. Boudes M. Gevaert T. . (2012). The use of cystometry in small rodents: a study of bladder chemosensation. J Vis. Exp. 66:e3869. 10.3791/386922929055 Uvin P. Franken J. Pinto S. Rietjens R. Grammet L. Deruyver Y. . (2015). Essential role of transient receptor potential M8 (TRPM8) in a model of acute cold-induced urinary urgency. Eur. Urol. 68, 655–661. 10.1016/j.eururo.2015.03.03725843641 Wilson T. S. Aziz K. A. Vazques D. Wuermser L. A. Lin V. K. Lemack G. E. (2005). Changes in detrusor smooth muscle myosin heavy chain mRNA expression following spinal cord injury in the mouse. Neurourol. Urodyn. 24, 89–95. 10.1002/nau.2007715468195 Wong K. Boone T. B. Wong S. T. Munoz A. (2015). Functional brain interactions during reflexive micturition are absent from spinal cord injured rats with neurogenic bladder. Neurourol. Urodyn. 34, 469–474. 10.1002/nau.2259624668445 Yoshiyama M. Araki I. Kobayashi H. Zakoji H. Takeda M. (2010). Functional roles of TRPV1 channels in lower urinary tract irritated by acetic acid: in vivo evaluations of the sex difference in decerebrate unanesthetized mice. Am. J. Physiol. Renal Physiol. 298, F1351–F1359. 10.1152/ajprenal.00695.200920237234 Yoshiyama M. Kobayashi H. Araki I. Du S. Zakoji H. Takeda M. (2008). Sex-related differences in activity of lower urinary tract in response to intravesical acid irritation in decerebrate unanesthetized mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 295, R954–R960. 10.1152/ajpregu.90406.200818650315 Yoshiyama M. Mochizuki T. Nakagomi H. Miyamoto T. Kira S. Mizumachi R. . (2015). Functional roles of TRPV1 and TRPV4 in control of lower urinary tract activity: dual analysis of behavior and reflex during the micturition cycle. Am. J. Physiol. Renal Physiol. 308, F1128–F1134. 10.1152/ajprenal.00016.201525761879 Yoshiyama M. Roppolo J. R. de Groat W. C. (1993a). Effects of MK-801 on the micturition reflex in the rat–possible sites of action. J. Pharmacol. Exp. Ther. 265, 844–850. 8496829 Yoshiyama M. Roppolo J. R. Takeda M. de Groat W. C. (2013). Effects of urethane on reflex activity of lower urinary tract in decerebrate unanesthetized rats. Am. J. Physiol. Renal Physiol. 304, F390–F396. 10.1152/ajprenal.00574.201223195677 Yoshiyama M. Roppolo J. R. Thor K. B. de Groat W. C. (1993b). Effects of LY274614, a competitive NMDA receptor antagonist, on the micturition reflex in the urethane-anaesthetized rat. Br. J. Pharmacol. 110, 77–86. 8106110 Yu W. Ackert-Bicknell C. Larigakis J. D. MacIver B. Steers W. D. Churchill G. A. . (2014). Spontaneous voiding by mice reveals strain-specific lower urinary tract function to be a quantitative genetic trait. Am. J. Physiol. Renal Physiol. 306, F1296–F1307. 10.1152/ajprenal.00074.201424717733 Zvara P. Wright A. J. Roach K. Ursiny M. Shapiro B. Dagrosa L. M. . (2010). A non-anesthetized mouse model for recording sensory urinary bladder activity. Front. Neurol. 1:127. 10.3389/fneur.2010.0012721188259 Abbreviations BOO

bladder outlet obstruction

 BP

basal pressure

 BPH

benign prostatic hyperplasia

 BPS

bladder pain syndrome

 DSD

detrusor sphincter dyssynergia

 EMG

Electromyography

 EUS

the external urethral sphincter

 FVC

frequency-volume chart

 LUTS

lower urinary tract symptom

 NVCs

non-voiding contractions

 OAB

overactive bladder

 PAG

periaqueductal gray

 PMC

pons micturition center

 SCI

Spinal cord injury

 TP

threshold pressure

 VSA

voiding spot assays.